Knight Therapeutics Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-3.49	4.33	-16.84	-29.89	15.68	31.76
Depreciation & Amortization	55.46	53.11	50.4	62.62	47.92	32.08
Stock-Based Compensation	4.69	1.86	2.33	1.89	3.05	1.95
Other Adjustments	-1.29	-3.4	28.06	15.85	-22.64	-54.33
Changes in Other Operating Activities	-19.8	-19.62	-28.01	-5.47	0.63	-23.66
Operating Cash Flow	35.55	36.28	35.94	45	44.62	-12.21
Operating Cash Flow Growth	-32.60%	0.95%	-20.14%	0.86%	-	-
Capital Expenditures	-1.96	-2.47	-0.95	-2.89	-3.83	-5.38
Sale of Property, Plant & Equipment	0.13	0.1	1.92	-	-	-
Purchases of Intangible Assets	-30.75	-29	-9.01	-22.93	-220.35	-15.29
Purchases of Investments	-45.13	-162.57	-334.16	-188.21	-64.32	-61.31
Proceeds from Sale of Investments	144.67	210.91	371.54	150.95	183.23	277.18
Payments for Business Acquisitions	-110.08	-	-	-	-	-170.86
Proceeds from Business Divestments	-	-	-	-	-	77
Other Investing Activities	0.4	-	-	-	-	-
Investing Cash Flow	-52.53	16.96	29.34	-63.08	-105.28	101.35
Long-Term Debt Issued	111.75	3.47	4.8	51.78	9.42	24.58
Long-Term Debt Repaid	-67.13	-17.61	-19.97	-17.54	-20.6	-14.71
Net Long-Term Debt Issued (Repaid)	44.62	-14.14	-15.17	34.24	-11.18	9.87
Issuance of Common Stock	0.52	1	0.38	0.34	0.3	0.83
Repurchase of Common Stock	-8.5	-8.87	-53.48	-30.07	-64.42	-36.79
Net Common Stock Issued (Repurchased)	-7.98	-7.86	-53.1	-29.73	-64.12	-35.96
Other Financing Activities	-11.79	-11.54	-12.73	-7.27	-3.02	-3.14
Financing Cash Flow	24.85	-33.54	-81	-2.76	-78.31	-29.23
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.24	1.64	2.8	6.55	-4.66	-4.59
Net Cash Flow	7.88	19.7	-15.72	-20.84	-138.97	59.92
Free Cash Flow	33.59	33.81	34.99	42.12	40.79	-17.58
Free Cash Flow Growth	-0.65%	-3.37%	-16.92%	3.26%	-	-
FCF Margin	8.12%	9.11%	10.66%	14.35%	16.75%	-8.81%
Free Cash Flow Per Share	0.34	0.33	0.33	0.37	0.33	-0.13
Levered Free Cash Flow	78.85	18.93	-15.73	44.55	40.22	54.65
Unlevered Free Cash Flow	30.69	38.41	18.54	13.22	31.88	-26.99

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.